Potential of Cytokines in the Management of Intervertebral Disc Degeneration

Huiyang Yu

doi:10.62051/qkg2zt96

Authors

Huiyang Yu

DOI:

https://doi.org/10.62051/qkg2zt96

Keywords:

Intervertebral disc; intervertebral disc degeneration; cytokines

Abstract

The illness known as intervertebral disc degeneration (IDD) is characterized by discomfort in the intervertebral discs. The IDD is made up of the annulus fibrosus (AF) and nucleus pulposus (NP), which function as a joint and cushion for the spine. IDD can develop with ageing, which can cause the NP to herniate and cause pain. IDD patients experience detrimental effects on their quality of life and mental health in addition to their physical health. It also poses a critical economic burden on society as a whole. Imaging techniques used for the diagnosis are disc herniation, X-ray plain film, CT, and MRI are discussed as imaging modalities, with MRI being particularly useful for diagnosing disc herniation. Treatment approaches range from conservative methods to surgical intervention, related to the type of IDD. Nonsteroidal anti-inflammatory medications, rest, traction therapy, and physical therapy are examples of non-surgical therapies. Options for surgery include conventional open surgery, microsurgical lumbar discectomy, minimally invasive IVD removal surgery, and artificial IVD replacement surgery. Many studies are focused on the role of cytokines to explain the cause of IDD. And these cytokines can be classified as cell cycle inhibitor, proinflammatory factor and growth factor. The article highlights cell cycle inhibitors (p16INK4a and p53), proinflammatory factors (IL-1β and TNF-α), and growth factor (TGF-β) involvement in IDD. However, currently, there are no cytokine-based treatments available for IDD in clinical practice. Future research could focus on developing new treatment or prevention targets for IL-1β or TNF-α.

Downloads

Download data is not yet available.

References

Brinjikji, W., et al., Systematic literature review of imaging features of spinal degeneration in asymptomatic populations. AJNR Am J Neuroradiology, 2015. 36 (4): p. 811 - 6.

Brinjikji, W., et al., MRI Findings of Disc Degeneration are More Prevalent in Adults with Low Back Pain than in Asymptomatic Controls: A Systematic Review and Meta-Analysis. AJNR Am J Neuroradiol, 2015. 36 (12): p. 2394 - 9.

Wang, L., et al., Revealing the Immune Infiltration Landscape and Identifying Diagnostic Biomarkers for Lumbar Disc Herniation. Front Immunol, 2021. 12: p. 666355.

Zhang, A.S., et al., Lumbar Disc Herniation: Diagnosis and Management. Am J Med, 2023. 136 (7): p. 645 - 651.

Finnerup, N.B., R. Kuner, and T.S. Jensen, Neuropathic Pain: From Mechanisms to Treatment. Physiol Rev, 2021. 101 (1): p. 259 - 301.

Li, Y., V. Fredrickson, and D.K. Resnick, how should we grade lumbar disc herniation and nerve root compression? A systematic review. Clin Orthop Relat Res, 2015. 473 (6): p. 1896 - 902.

Zhang, B., et al., A narrative review of non-operative treatment, especially traditional Chinese medicine therapy, for lumbar intervertebral disc herniation. Biosci Trends, 2017. 11 (4): p. 406 - 417.

Armin, S.S., L.T. Holly, and L.T. Khoo, minimally invasive decompression for lumbar stenosis and disc herniati on. Neurosurgical focus. 25 (2): p. E11.

Wang, H., et al., Inflammatory cytokines induce NOTCH signaling in nucleus pulposus cells: implications in intervertebral disc degeneration. J Biol Chem, 2013. 288 (23): p. 16761 - 16774.

Wang, Y., et al., Emerging role and therapeutic implications of p53 in intervertebral disc degeneration. Cell Death Discov, 2023. 9 (1): p. 433.

Zhang, Y., et al., Interleukin-9 Promotes TNF-α and PGE2 Release in Human Degenerated Intervertebral Disc Tissues. Spine (Phila Pa 1976), 2016. 41 (21): p. 1631 - 1640.

Che, H., et al., p16 deficiency attenuates intervertebral disc degeneration by adjusting oxidative stress and nucleus pulposus cell cycle. Elife, 2020. 9.

Ohtani, N., et al., The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression. J Med Invest, 2004. 51 (3-4): p. 146 - 53.

Wang, Y., et al., The role of IL-1β and TNF-α in intervertebral disc degeneration. Biomed Pharmacother, 2020. 131: p. 110660.

Zhang, K., et al., Upregulation of P53 promotes nucleus pulposus cell apoptosis in intervertebral disc degeneration through upregulating NDRG2. Cell Biol Int, 2021. 45 (9): p. 1966 - 1975.

Le Maitre, C.L., A.J. Freemont, and J.A. Hoyland, Accelerated cellular senescence in degenerate intervertebral discs: a possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Res Ther, 2007. 9 (3): p. R45.

Novais, E.J., et al., p16(Ink4a) deletion in cells of the intervertebral disc affects their matrix homeostasis and senescence associated secretory phenotype without altering onset of senescence. Matrix Biol, 2019. 82: p. 54 - 70.

Cuéllar, J.M., et al., Cytokine expression in the epidural space: a model of no compressive disc herniation-induced inflammation. Spine (Phila Pa 1976), 2013. 38 (1): p. 17 - 23.

Le Maitre, C.L., A.J. Freemont, and J.A. Hoyland, The role of interleukin-1 in the pathogenesis of human intervertebral disc degeneration. Arthritis Res Ther, 2005. 7 (4): p. R732 - 45.

Li, H., et al., The mechanisms and functions of IL-1β in intervertebral disc degeneration. Exp Gerontol, 2023. 177: p. 112181.

Kepler, C.K., et al., Expression and relationship of proinflammatory chemokine RANTES/CCL5 and cytokine IL-1β in painful human intervertebral discs. Spine (Phila Pa 1976), 2013. 38 (11): p. 873 - 80.

Xue, Z., X. Zhang, and N. Cheng, The role of interleukin in intervertebral disc degeneration. Orthopedic Journal of China, 2023. 31 (04): p. 341 - 345.

Andrade, P., et al., Tumor necrosis factor-α levels correlate with postoperative pain severity in lumbar disc hernia patients: opposite clinical effects between tumor necrosis factor receptor 1 and 2. Pain, 2011. 152 (11): p. 2645 - 2652.

Li, W., et al., IL-10 and TGF- β In vitro experimental study on biological therapy mediated by canine intervertebral disc degeneration. Chinese Journal of Bone and Joint, 2015. 4 (03): p. 230 - 234.

Chen, S., et al., TGF-β signaling in intervertebral disc health and disease. Osteoarthritis Cartilage, 2019. 27 (8): p. 1109 - 1117.

Zhao, Y., et al., Tissue Engineering Material KLD-12 Polypeptide /TGF-β1 the Protective Effect and Mechanism of Nanofiber Gel on Early Intervertebral Disc Degeneration. Cell Mol Biol (Noisy-le-grand), 2022. 68 (3): p. 282 - 293.